Demy-Colton to Convene More than 700 BioFuturists Shaping What‘s Next in Healthcare

BioFuture 2023 Returns to New York City October 4-6

NEW YORK--(BUSINESS WIRE)--This Fall, BioFuture™ will convene more than 700 therapeutic pioneers, innovators, journalists and investors – today’s BioFuturists – in candid, unfiltered conversations and in-person and virtual networking about the technologies and trends shaping the future of bioscience, digital technology and healthcare. Hosted by Demy-Colton, a leader in connecting biopharma, life science and digital health executives, this year’s conference will return to New York City’s Lotte New York Palace on October 4. The conference will feature three days of unfiltered plenary session dialog, unscripted interviews, company presentations, workshops and networking about the seismic shifts in healthcare innovation... how it’s discovered, how it’s developed and how it’s delivered.

The 700 plus attendees, including more than 100 high-profile speakers from companies and organizations such as Google, Stanford University, Eli Lilly & Company, Regeneron, Scientific American, Thermo Fisher and more will explore the impact on innovation of the convergence of rapidly evolving fields. Attendees will dive into engaging and future-focused themes, such as:

• The Genetic Revolution: Personalized Medicines, Gene Editing, and Beyond
• Surviving the Storm: Tackling Healthcare Challenges Amid Climate, Environmental, and Social Shifts
• Beating the ‘Unbeatable’: Pioneering Treatments for Previously Incurable Diseases

“At BioFuture we want to color outside of the lines; we want to ask difficult questions such as How Come? Why Not? and What can we do to make healthcare better?” said Sara Demy, CEO & Founder of Demy-Colton. “With a focus on open collaboration, we're not just discussing the future of healthcare. We're creating it.”

BioFuture will be held live October 4-6, 2023. A virtual partnering option will also be offered from October 10-12, including access to the event’s recorded content. Innovative public, private and seed companies are encouraged to submit an application to present at BioFuture. The Presenting Company Selection Committee seeks public and private companies developing new therapeutics as well as companies engaged in facilitating the discovery of new therapeutic technologies across biotech, digital medicine, AI, machine learning and big data.

For information on presentation or sponsorship opportunities, please contact Lila Taylor at [e-mail]. For more information about BioFuture or to register, please visit www.biofuture.com and follow #BioFuture2023 on Twitter for the latest updates and discussions.

About Demy-Colton

Demy-Colton is a leading life sciences and digital health events organization, at the forefront of building networks between innovative life sciences companies and industry stakeholders. Its unique events facilitate networking on a global scale, including Biotech Showcase™, BioFuture™, Biotech CEO Summit Europe™, Biotech CEO Summit in La Jolla, and Demy-Colton Virtual Salons. These events build networking communities that transcend geographical boundaries and establish ongoing, high-value relationships among the industry’s top decision-makers, investors and thought leaders, where investment, learning, and thoughtful conversations thrive. For more information, visit www.demy-colton.com.